RecruitingNot ApplicableNCT07068477
Adaptation of a Values Assessment Tool
Values Assessment Tailored for Women With Metastatic Breast Cancer and Their Caregivers: Adaptation and Pilot Study of a Values Assessment Tool (VAsT)
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
40 participants
Start Date
Jan 5, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The primary purpose of this study is to evaluate the effect of values assessment tool on patient and caregiver perception of decisional conflict, and communication with their oncology clinician.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- Age ≥18 years
- Diagnosed with metastatic breast cancer.
- Understand and read English.
- Receive care or anticipate receiving care at the North Carolina Cancer Hospital ambulatory cancer clinic or affiliated community cancer clinic.
- Able to understand and participate in study procedures for length of study.
Exclusion Criteria3
- Unable to provide consent, unable to communicate verbally.
- Unable to understand or read English.
- Enrolled in hospice care.
Interventions
BEHAVIORALValues Assessment Tool
The Values Assessment Tool was provided to the participants at baseline and every clinic visit for 3 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07068477
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT066493311 location
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
NCT059645044 locations
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT0708576735 locations
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
NCT0342400545 locations